| Sunday 22 September |
Monday 23 September |
Tuesday 24 September |
| 11:00 – 13:00 |
11:15 – 13:15 |
09:00 – 11:00 |
|
Quantitative analysis of signalling
Alexander van Oudenaarden, NL
Speaker selected from abstracts
Ray Deshaies, US
Speaker selected from abstracts
Michael B. Yaffe, US
|
Cancer genomics
Olli Kallioniemi, FI
Speaker selected from abstracts
René Bernards, NL
Speaker selected from abstracts
James Brenton, UK
|
Cell division
Geert Kops, NL
Speaker selected from abstracts
Iain Hagan, UK
Speaker selected from abstracts
David M. Glover, UK
|
|
Cell Polarity
Juergen Knoblich, AT
Speaker selected from abstracts
Geraldine Seydoux, US
Speaker selected from abstracts
Wieland Huttner, DE
|
Host pathogen interaction
TBA
Speaker selected from abstracts
Yoshi Kawaoka, US
Speaker selected from abstracts
Alexandra Trkola, CH
|
Membrane organization
Petra Schwille, DE
Speaker selected from abstracts
Ilpo Vattulainen, FI
Speaker selected from abstracts
Sarah Veatch, US
|
|
|
|
|
Membrane trafficking
Jacques Neefjes, NL
Speaker selected from abstracts
Ludger Johannes, FR
Speaker selected from abstracts
Antonella De Matteis, IT
|
Nuclear substructure
Liesbeth M. Veenhoff, NL
Speaker selected from abstracts
Wouter de Laat, NL
Speaker selected from abstracts
Karla Neugebauer, DE
|
Vaccines
Antonio Lanzavecchia, CH
Speaker selected from abstracts
Rino Rappuoli, IT
Speaker selected from abstracts
Albert Osterhaus, NL
|
|
New technologies for transgenesis and tissue visualization
J Keith Joung, US
Speaker selected from abstracts
Claude Pierre Lechene, US
Speaker selected from abstracts
Aron M. Geurts, US
|
New methods at organismal level: optogenetics
Ed Boyden, US
Speaker selected from abstracts
Marco Tripodi, UK
Speaker selected from abstracts
Arthur Konnerth, DE
|
New methods in genomics
Kári Stefánsson, IS
Speaker selected from abstracts
Peer Bork, DE
Speaker selected from abstracts
L. Stirling Churchman, US
|
| Sunday 22 September |
Monday 23 September |
How to plan your concurrent session schedule
The concurrent sessions at The EMBO Meeting aim to provide a snapshot of what is currently happening in life science research. The conference chairs have devised the program in such a way that concurrent sessions that focus on similar research areas do not run in parallel. The different colours indicate the broad areas that are being discussed at the molecular, organismal, cellular and methodological level.
|
| 14:30 – 16:30 |
15:00 – 17:00 |
|
Stem cell signalling
Cédric Blanpain, BE
Speaker selected from abstracts
Ben Scheres, NL
Speaker selected from abstracts
Anjana Rao, US
|
Epigenetics
Geneviève Almouzni, FR
Speaker selected from abstracts
Susan M. Gasser, CH
Speaker selected from abstracts
A. Francis Stewart, DE
|
|
Non Coding RNAs
Reuven Agami, NL
Speaker selected from abstracts
Joan A. Steitz, US
Speaker selected from abstracts
René Ketting, NL
|
Targeting DNA repair
Roland Kanaar, NL
Speaker selected from abstracts
Thomas Helleday, SE
Speaker selected from abstracts
Penny Jeggo, UK
|
|
|
Membranes in development
Mikael Simons, DE
Speaker selected from abstracts
Verena Göbel, US
Speaker selected from abstracts
François Schweisguth, FR
|
Cytoskeleton dynamics
Anna Akhmanova, NL
Speaker selected from abstracts
Marileen Dogterom, NL
Speaker selected from abstracts
Carolyn Moores, UK
|
|
|
Imaging technologies
Pavel Tomancak, DE
Speaker selected from abstracts
Jan Ellenberg, DE
Speaker selected from abstracts
Peter Friedl, NL
|
New methods in analyzing protein complexes
Holger Stark, DE
Speaker selected from abstracts
Henry N. Chapman, DE
Speaker selected from abstracts
Charalampos Kalodimos, US
|
|